CEO, Gemini Pharmaceuticals
Michael Finamore is CEO of Gemini Pharmaceuticals Inc., a contract manufacturer of both dietary supplements and over-the-counter (OTC) pharmaceuticals for more than 30 years. All Gemini production is carried out in a pharmaceutical cGMP (current good manufacturing practice) environment.
Latest from Michael Finamore
All from Michael Finamore
iHerb joins Amazon in stopping sales of NMN supplementsFeb 27, 2024|2 Min Read
Family Dollar to pay $41.7 million fine over rodent infested warehouseFeb 27, 2024|3 Min Read
The changing history of women’s nutritional ingredients over the yearsFeb 26, 2024|5 Min Read
Third-party certification weeds out banned ingredientsFeb 26, 2024|3 Min Read